In vitro antileishmanial properties of new flavonoids against Leishmania donovani

Biomedicine and Preventive Nutrition

Volumn 1, Issue 3, 2011, Pages 168-171

  Lewin, G ^a   Cojean, S ^a   Gupta, S ^b   Verma, A ^b   Puri, S K ^b   Loiseau, P M ^a  

^a UNIVERSITÉ PARIS SUD   (France)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Antileishmanial drugs; Flavonoids; Leishmania donovani; Luciferase assay

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 7 HYDROXYETHOXYFLAVONE; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; FLAVONOID; LUCIFERASE; MILTEFOSINE; QUERCETIN; SITAMAQUINE; UNCLASSIFIED DRUG;

AMASTIGOTE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG DETERMINATION; DRUG SCREENING; DRUG STRUCTURE; GROWTH INHIBITION; IC 50; IN VITRO STUDY; LEISHMANIA DONOVANI; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; REPORTER GENE;

EID: 83655182303     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2011.06.012     Document Type: Article

References (13)

1. Harborne J.B., Williams C.A. Advances in flavonoid research since 1992. Phytochem 2000, 55:481-504.
2. Marin C., Boutaleb-Charki S., Diaz J.G., et al. Antileishmaniasis activity of flavonoids from Consolida oliveriana. J Nat Prod 2009, 72:1069-1074.
3. Lewin G., Rolland Y., Privat S., et al. Synthesis and evaluation of 3′,5′-di-tert.-butyl-4′-hydroxy flavones as potential inhibitors of low density lipoproteins (LDL) oxidation. J Nat Prod 1995, 58:1840-1847.
4. Ferté J., Kühnel J.-M., Chapuis G., et al. Flavonoid-related modulators of multidrug resistance: synthesis, pharmacological activity, and structure-activity relationships. J Med Chem 1999, 42:478-489.
5. EP0832886 Flavon derivatives, process for their preparation, and pharmaceutical compositions containing them.
6. Chollet C., Crousse B., Bories C., et al. In vitro antileishmanial activity of fluoro-artemisinin derivatives against Leishmania donovani. Biomed Pharmacother 2008, 62:462-465.
7. Sunduru N., Nishi, Palne S., et al. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines. Eur J Med Chem 2009, 44:2473-2481.
8. Gupta L., Talwar A., Nishi, et al. Synthesis of marine alkaloid: 8,9-dihydrocoscinamide B and its analogues as novel class of antileishmanial agents. Bioorg Med Chem Lett 2007, 17:4075-4079.
9. 50in studies of drug resistance of malaria parasites. Acta Trop 1993, 55:257-261.
10. Tasdemir D., Kaiser M., Brun R., et al. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship and quantitative structure-activity relationship studies. Antimicrob Agents Chemother 2006, 50:1352-1364.
11. Mittra B., Saha A., Chowdhury A.R., et al. Luteolin, an abundant dietary component is a potent antileishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis. Mol Med 2000, 6:527-541.
12. Muzitano M.F., Falcao C.A.B., Cruz E.A., et al. Oral metabolism and efficacy of Kalanchoe pinnata flavonoids in a murine model of cutaneous leishmaniasis. Planta Med 2009, 75:307-311.
13. Sen G., Biswas D., Ray M., et al. Albumin-quercetin combination offers a therapeutic advantage in the prevention of reduced survival of erythrocytes in visceral leishmaniasis. Blood Cells Mol Dis 2007, 39:245-254.